Stanley Cohen Innovation Fund

Emily Hodges and Terunaga Nakagawa were named as the 2022 Stanley Cohen Innovation Fund recipients. Read More

A team including the Sanders lab developed a new methodology for finding small molecules associated with lipid rafts, an essential part of cell structure and regulation. Read More

Houra Merrikh, professor of biochemistry, and Teru Nakagawa, associate professor of molecular physiology and biophysics, have both been selected to receive one-year research awards from the Stanley Cohen Innovation Fund. The awards will support groundbreaking and paradigm-shifting research. Read More

Cody Siciliano, PhD, assistant professor of Pharmacology in the Vanderbilt University School of Medicine, has been selected to receive a one-year, $100,000 research award from the Stanley Cohen Innovation Fund to support his studies of the neural substrates of memory. Read More

Stanley Cohen, a legendary Vanderbilt University biochemist who was awarded the Nobel Prize for the discovery of epidermal growth factor and its receptor, died on Feb. 5 at the age of 97. Read More

The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells. Read More

Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment. Read More

The Vanderbilt University School of Medicine is now soliciting applications for research awards from the Stanley Cohen Innovation Fund. Read More

When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF). Read More